• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Survey Exploring People's Experiences With Lithium Bought as a Supplement: Une enquête sur l'expérience des personnes avec le lithium en supplément.一项探索人们购买锂补充剂的经历的调查:关于人们使用锂补充剂的经历的调查。
Can J Psychiatry. 2025 Mar 28:7067437251328282. doi: 10.1177/07067437251328282.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
5
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
6
Sexual Harassment and Prevention Training性骚扰与预防培训
7
"In a State of Flow": A Qualitative Examination of Autistic Adults' Phenomenological Experiences of Task Immersion.“心流状态”:对自闭症成年人任务沉浸现象学体验的质性研究
Autism Adulthood. 2024 Sep 16;6(3):362-373. doi: 10.1089/aut.2023.0032. eCollection 2024 Sep.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
10
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.左乙拉西坦添加治疗耐药性局灶性癫痫:Cochrane系统评价的更新版
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001901. doi: 10.1002/14651858.CD001901.pub2.

本文引用的文献

1
Comparing measurements of lithium treatment efficacy in people with bipolar disorder: systematic review and meta-analysis - CORRIGENDUM.双相情感障碍患者锂治疗疗效测量的比较:系统评价与荟萃分析——勘误
BJPsych Open. 2024 Nov 13;10(6):e210. doi: 10.1192/bjo.2024.807.
2
Lithium: how low can you go?锂:你能降到多低?
Int J Bipolar Disord. 2024 Jan 30;12(1):4. doi: 10.1186/s40345-024-00325-y.
3
Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis.在轻度认知障碍和阿尔茨海默病患者中,比较 donanemab、lecanemab、aducanumab 和锂对认知功能的疗效、耐受性和可接受性:一项系统评价和网络荟萃分析。
Ageing Res Rev. 2024 Feb;94:102203. doi: 10.1016/j.arr.2024.102203. Epub 2024 Jan 20.
4
Different pharmacokinetics of lithium orotate inform why it is more potent, effective, and less toxic than lithium carbonate in a mouse model of mania.不同的奥氮平药代动力学解释了为什么它在躁狂症的小鼠模型中比碳酸锂更有效、更有效、毒性更小。
J Psychiatr Res. 2023 Aug;164:192-201. doi: 10.1016/j.jpsychires.2023.06.012. Epub 2023 Jun 17.
5
Clinicians' preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force.全球临床医生对锂盐用于双相情感障碍维持治疗的偏好与态度:国际双相障碍学会锂盐工作组的一项调查
Int J Bipolar Disord. 2023 May 27;11(1):20. doi: 10.1186/s40345-023-00301-y.
6
Identifying the neuropsychiatric health effects of low-dose lithium interventions: A systematic review.确定低剂量锂干预对神经精神健康的影响:一项系统综述。
Neurosci Biobehav Rev. 2023 Jan;144:104975. doi: 10.1016/j.neubiorev.2022.104975. Epub 2022 Nov 24.
7
Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression.系统评价和荟萃分析早期治疗抵抗性抑郁症的增效和联合治疗。
J Psychopharmacol. 2023 Mar;37(3):268-278. doi: 10.1177/02698811221104058. Epub 2022 Jul 21.
8
Do food and nutrition have therapeutic value for disorders of mood and conation?食物和营养对情绪和意动障碍是否具有治疗价值?
Ind Psychiatry J. 2022 Jan-Jun;31(1):1-5. doi: 10.4103/ipj.ipj_68_22. Epub 2022 May 20.
9
Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment.锂盐和喹硫平增效治疗在治疗抵抗性抑郁症中的患者观点:定性评估。
J Psychopharmacol. 2022 May;36(5):557-565. doi: 10.1177/02698811221089042. Epub 2022 Apr 27.
10
The role of lithium treatment on comorbid anxiety symptoms in patients with bipolar depression.锂治疗对双相抑郁患者共病焦虑症状的作用。
J Affect Disord. 2022 Jul 1;308:71-75. doi: 10.1016/j.jad.2022.04.025. Epub 2022 Apr 12.

一项探索人们购买锂补充剂的经历的调查:关于人们使用锂补充剂的经历的调查。

A Survey Exploring People's Experiences With Lithium Bought as a Supplement: Une enquête sur l'expérience des personnes avec le lithium en supplément.

作者信息

Strawbridge Rebecca, Myrtle Samuel, Carmellini Pietro, Hampsey Elliot, Cousins David A, Young Allan H

机构信息

Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

School of Clinical Medicine, University of Cambridge, Cambridge, UK.

出版信息

Can J Psychiatry. 2025 Mar 28:7067437251328282. doi: 10.1177/07067437251328282.

DOI:10.1177/07067437251328282
PMID:40152059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11954165/
Abstract

ObjectiveLithium, despite its evidence base and range of indications, is often underutilized due to safety concerns associated with high-dose prescriptions and consequent necessity for regular blood monitoring. Emerging evidence suggests its potential benefits at lower doses, especially for its pro-cognitive effects and positive safety profile. While accessible as a supplement, empirical human evidence on neuropsychiatric effects is lacking. This study aimed to provide preliminary evidence regarding the utilization and perceived effects of low-dose lithium supplements (LiS) in the community.MethodsCross-sectional, opportunistic survey of 211 participants aged ≥18 years who disclosed taking over-the-counter lithium supplements. The survey assessed sample demographics, supplement details, overall perspectives, and personal experiences related to the use of LiS.ResultsThe most common form of LiS taken was aspartate at 10 mg once per day, although lithium orotate and ionic lithium were also frequently used. The most common beliefs regarding the benefits of using lithium as a supplement concern efficacy for anxiety, but the most common improvements experienced was in the domain of cognition, closely followed by anxiety and mood. Mood was most commonly reported as the greatest improvement. Side effects and withdrawal phenomena were more prevalent than anticipated.ConclusionThis study revealed a diverse range of lithium supplements taken, in terms of dosage, formulation, frequency, and duration of intake. Anecdotal evidence highlighted prevalent perceived benefits and adverse effects. The study is, however, limited notably by its cross-sectional opportunistic design; more robust evidence, especially from controlled trials, is needed to fully establish the specific benefits and drawbacks associated with different forms and doses of accessible lithium supplements.Plain Language Summary TitleA survey exploring people's experiences with lithium bought as a supplement.Lithium is the oldest effective medication used in psychiatry and holds an important place today. However, there are challenges with lithium in high doses and it may still be effective in low doses. Lower doses of lithium can be bought as a supplement over the counter, but this version of lithium has not been studied in research. We did a survey aiming to tell us some information about the experiences of people who have taken this supplementary lithium ("LiS"). From 211 adults who completed our study, results suggested that LiS is taken in many different forms, at different doses, frequencies and for different durations. People commonly believed and/or found that LiS was beneficial for anxiety, mood and cognition. Side effects and symptoms after stopping LiS were, however, more common than expected. Because this was just an initial survey, more in depth and rigorous research studies are needed to fully understand the exact benefits and drawbacks associated with different forms and doses of accessible lithium supplements.

摘要

目的

锂盐尽管有循证依据且适应证广泛,但由于高剂量处方相关的安全问题以及随之而来的定期血液监测的必要性,其使用常常不足。新出现的证据表明其在低剂量时有潜在益处,尤其是对认知的促进作用和良好的安全性。虽然锂盐可作为补充剂获取,但缺乏关于其神经精神效应的实证性人体证据。本研究旨在提供关于社区中低剂量锂补充剂(LiS)的使用情况和感知效果的初步证据。

方法

对211名年龄≥18岁且透露正在服用非处方锂补充剂的参与者进行横断面机会性调查。该调查评估了样本的人口统计学特征、补充剂细节、总体看法以及与LiS使用相关的个人经历。

结果

服用的LiS最常见形式是天冬氨酸盐,每天10毫克,尽管乳清酸锂和离子锂也经常被使用。关于将锂作为补充剂使用的益处,最常见的看法是对焦虑有效,但最常体验到改善的领域是认知,其次是焦虑和情绪。情绪方面最常被报告为改善最大。副作用和戒断现象比预期更普遍。

结论

本研究揭示了在剂量、剂型、服用频率和持续时间方面服用的锂补充剂种类繁多。轶事证据突出了普遍感知到的益处和不良反应。然而,该研究显著受限于其横断面机会性设计;需要更有力的证据,尤其是来自对照试验的证据,以充分确定与不同形式和剂量的可获取锂补充剂相关的具体益处和缺点。

通俗易懂的总结标题

一项探索人们使用购买的锂补充剂经历的调查

锂是精神病学中使用最久的有效药物,如今仍占有重要地位。然而,高剂量锂存在挑战,低剂量时可能仍有效。低剂量锂可作为非处方药补充剂购买,但这种锂版本尚未在研究中得到研究。我们进行了一项调查,旨在了解服用这种补充性锂(“LiS”)的人的经历。从完成我们研究的211名成年人中,结果表明LiS有多种不同形式,服用剂量、频率和持续时间各不相同。人们普遍认为和/或发现LiS对焦虑、情绪和认知有益。然而,停止服用LiS后的副作用和症状比预期更常见。由于这只是一项初步调查,需要更深入和严谨的研究来充分了解与不同形式和剂量的可获取锂补充剂相关的确切益处和缺点。